Worg Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 17

Worg General Information

Description

Developer of a clinical-stage biopharmaceutical company intended to find treatments for allergies and diseases with high unmet medical needs and considerable commercial potential. The company offers building a pipeline for immunotherapy of allergies, autoimmune diseases, and other disorders through internal development and external partnering, enabling the acceleration of new treatment development.

Contact Information

Formerly Known As
Baiming Xinkang Biotechnology (Hangzhou)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building 20, Pujiang Zhigu Business Park
  • Number 1188 Lianhang Road, Minhang District
  • Shanghai, 201315
  • China
+86 021
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5th Floor, Building 20, Pujiang Zhigu Business Park
  • Number 1188 Lianhang Road, Minhang District
  • Shanghai, 201315
  • China
+86 021

Worg Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Worg Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 27-Nov-2025 Completed Generating Revenue
7. Later Stage VC (Series D1) 06-Aug-2025 Completed Generating Revenue
6. Later Stage VC 25-Jun-2025 Completed Generating Revenue
5. Later Stage VC (Series D) 20-Nov-2024 Completed Generating Revenue
4. Later Stage VC 29-Feb-2024 Completed Generating Revenue
3. Later Stage VC (Series C) 28-Jun-2023 Completed Generating Revenue
2. Early Stage VC (Series B) 26-Aug-2022 $59M $89.5M Completed Generating Revenue
1. Early Stage VC (Series A) 21-Dec-2020 $30.5M $30.5M Completed Generating Revenue
To view Worg’s complete valuation and funding history, request access »

Worg Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical-stage biopharmaceutical company intended to find treatments for allergies and diseases with high
Drug Delivery
Shanghai, China
40 As of 2022

Huzhou, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Worg Competitors (1)

One of Worg’s competitors is Wolwo Pharma, a Formerly VC-backed company based in Huzhou, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Wolwo Pharma Formerly VC-backed Huzhou, China
You’re viewing 1 of 1 competitors. Get the full list »

Worg Patents

Worg Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026119129-A1 Paper mulberry pollen allergen and use thereof Pending 04-Dec-2024
JP-2025537236-A Allergy treatment vaccines Pending 07-Nov-2022
AU-2022485375-A1 Vaccine for treating allergies Pending 07-Nov-2022
EP-4615499-A1 Vaccine for treating allergies Pending 07-Nov-2022
EP-4615499-A4 Vaccine for treating allergies Pending 07-Nov-2022 A61P37/08
To view Worg’s complete patent history, request access »

Worg Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Worg Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hefei Hi-Tech VC Venture Capital Minority
LongRiver Investments Venture Capital Minority
PICC Capital Insurance Asset Management Asset Manager Minority
Shenzhen Investment Holdings Asset Manager Minority
Wuxi Jinkong Qiyuan Investment PE/Buyout Minority
You’re viewing 5 of 17 investors. Get the full list »

Worg Acquisitions (2)

Worg’s most recent deal was a Merger/Acquisition with Diater Laboratorio de Diagnóstico y Aplicaciones Terapéuticas for . The deal was made on 01-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Diater Laboratorio de Diagnóstico y Aplicaciones Terapéuticas 01-Oct-2023 Merger/Acquisition Pharmaceuticals
Apitope 21-Sep-2021 Merger/Acquisition Drug Discovery
To view Worg’s complete acquisitions history, request access »

Worg Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Diater Laboratorio de Diagnóstico y Aplicaciones Terapéuticas Madrid, Spain 1999

Worg FAQs

  • When was Worg founded?

    Worg was founded in 2018.

  • Where is Worg headquartered?

    Worg is headquartered in Shanghai, China.

  • What is the size of Worg?

    Worg has 40 total employees.

  • What industry is Worg in?

    Worg’s primary industry is Drug Delivery.

  • Is Worg a private or public company?

    Worg is a Private company.

  • What is Worg’s current revenue?

    The current revenue for Worg is .

  • How much funding has Worg raised over time?

    Worg has raised $285M.

  • Who are Worg’s investors?

    Hefei Hi-Tech VC, LongRiver Investments, PICC Capital Insurance Asset Management, Shenzhen Investment Holdings, and Wuxi Jinkong Qiyuan Investment are 5 of 17 investors who have invested in Worg.

  • Who are Worg’s competitors?

    Wolwo Pharma is a competitor of Worg.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process